iBio (IBIO) Total Liabilities (2011 - 2026)

iBio (IBIO) has 16 years of Total Liabilities data on file, last reported at $8.3 million in Q1 2026.

• On a quarterly basis, Total Liabilities rose 7.45% year-over-year to $8.3 million in Q1 2026; TTM through Mar 2026 was $8.3 million, a 7.45% increase from a year earlier, with the FY2025 full-year figure at $8.3 million, up 12.08% from the prior year.
• Total Liabilities for Q1 2026 stood at $8.3 million, up from $7.8 million in the prior quarter.
• Over the last five years, Total Liabilities for IBIO reached as high as $36.2 million in Q3 2022 and fell as low as $6.8 million in Q3 2024.
• Historically, Total Liabilities has averaged $19.5 million across 5 years, with a median of $24.5 million in 2023.
• Across the five-year window, Total Liabilities sank 72.36% in 2024 and increased 20.01% in 2025, its largest moves.
• Year by year, Total Liabilities stood at $33.0 million in 2022, then retreated by 24.72% to $24.8 million in 2023, then slumped by 68.57% to $7.8 million in 2024, then increased by 0.4% to $7.8 million in 2025, then gained by 5.92% to $8.3 million in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $8.3 million in Q1 2026, $7.8 million in Q4 2025, and $8.1 million in Q3 2025.